Skip to main content
Erschienen in: The journal of nutrition, health & aging 2/2017

12.01.2017 | Editorial

Frailty – An emerging high impact complication of diabetes requiring specific management approaches

verfasst von: Alan Sinclair, B. Vellas

Erschienen in: The journal of nutrition, health & aging | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Excerpt

Ever since the Frailty model for diabetes was first described (1) a different management approach to older adults with diabetes who develop frailty has been suggested. The European Diabetes Working Party for Older People (EDWPOP) identified frailty as a key priority area for action (2) and published a glucose-lowering algorithm for frail patients with type 2 diabetes. More recently, the international Diabetes Federation (IDF) launched global guidance on the management of diabetes in older adults and made specific recommendations on treatment in those adults who are dependent and frail who depend on others for their diabetes care (3). Other organisations recognise the impact of multimorbidity and frailty in the overall management of older citizens with diabetes (4-6). We are pleased to announce that more considered guidance to this complex area of diabetes management is in development and in mid-2017, an international collaboration consisting of EDWPOP, IAGG-Garn, AMDA, ICFRSR, and an International Group of Experts, will publish a Position Statement in this area* (see list of collaborators at end of article). …
Literatur
1.
Zurück zum Zitat Sinclair AJ. Diabetes in old age—changing concepts in the secondary care arena. J R Coll Physicians Lond 2000;34:240–44.PubMed Sinclair AJ. Diabetes in old age—changing concepts in the secondary care arena. J R Coll Physicians Lond 2000;34:240–44.PubMed
2.
Zurück zum Zitat Sinclair AJ, Paolisso G, Castro M, Bourdel-Marchasson I, Gadsby R, Rodriguez Mañas L, European Diabetes Working Party for Older People. European Diabetes Working Party for Older People 2011 clinical guidelines References for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011;37 (suppl 3): S27–38.CrossRefPubMed Sinclair AJ, Paolisso G, Castro M, Bourdel-Marchasson I, Gadsby R, Rodriguez Mañas L, European Diabetes Working Party for Older People. European Diabetes Working Party for Older People 2011 clinical guidelines References for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011;37 (suppl 3): S27–38.CrossRefPubMed
3.
Zurück zum Zitat Dunning T, Sinclair AJ, Colagiuri S. New IDF Guideline for managing type 2 diabetes in older people. Diabetes Res Clin Pract. 2014 Mar;103(3):538–40.CrossRefPubMed Dunning T, Sinclair AJ, Colagiuri S. New IDF Guideline for managing type 2 diabetes in older people. Diabetes Res Clin Pract. 2014 Mar;103(3):538–40.CrossRefPubMed
4.
Zurück zum Zitat Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–79.CrossRefPubMedPubMedCentral Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–79.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Sinclair A, Morley JE, Rodriquez-Manas L, et al. Diabetes mellitus in older people: position statement on behalf of International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts of Diabetes. J Am Med Dir Assoc 2012;13:497–502.CrossRefPubMed Sinclair A, Morley JE, Rodriquez-Manas L, et al. Diabetes mellitus in older people: position statement on behalf of International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts of Diabetes. J Am Med Dir Assoc 2012;13:497–502.CrossRefPubMed
7.
Zurück zum Zitat Morley JE, Malmstrom TK, Rodriguez-Mañas L, Sinclair AJ. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc. 2014 Dec;15(12):853–9CrossRefPubMed Morley JE, Malmstrom TK, Rodriguez-Mañas L, Sinclair AJ. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc. 2014 Dec;15(12):853–9CrossRefPubMed
8.
Zurück zum Zitat Castro-Rodríguez M, Carnicero JA, Garcia-Garcia FJ, Walter S, Morley JE, Rodríguez-Artalejo F, Sinclair AJ, Rodríguez-Mañas L. Frailty as a Major Factor in the Increased Risk of Death and Disability in Older People With Diabetes. J Am Med Dir Assoc. 2016 Oct 1;17(10):949–55.CrossRefPubMed Castro-Rodríguez M, Carnicero JA, Garcia-Garcia FJ, Walter S, Morley JE, Rodríguez-Artalejo F, Sinclair AJ, Rodríguez-Mañas L. Frailty as a Major Factor in the Increased Risk of Death and Disability in Older People With Diabetes. J Am Med Dir Assoc. 2016 Oct 1;17(10):949–55.CrossRefPubMed
9.
Zurück zum Zitat Barnett AH, Huisman H, Jones R, von Eynatten M, Patel S, Woerle H-J. Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial. Lancet 2013; published online Aug 13. http://dx.doi.org/10.1016/S0140-6736(13)61500-7. Barnett AH, Huisman H, Jones R, von Eynatten M, Patel S, Woerle H-J. Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial. Lancet 2013; published online Aug 13. http://​dx.​doi.​org/​10.​1016/​S0140-6736(13)61500-7.
10.
Zurück zum Zitat Strain WD, Lukashevich V, Kothny W, Hoellinger MJ, Paldánius PM. Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study. Lancet 2013;382:409–16.CrossRefPubMed Strain WD, Lukashevich V, Kothny W, Hoellinger MJ, Paldánius PM. Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study. Lancet 2013;382:409–16.CrossRefPubMed
11.
Zurück zum Zitat Sinclair A, Morley J. Frailty and diabetes.. Lancet. 2013 Oct 26;382(9902):1386–7. doi: 10.1016/S0140-6736(13)61676-1. Epub 2013 Aug 13.CrossRefPubMed Sinclair A, Morley J. Frailty and diabetes.. Lancet. 2013 Oct 26;382(9902):1386–7. doi: 10.1016/S0140-6736(13)61676-1. Epub 2013 Aug 13.CrossRefPubMed
12.
Zurück zum Zitat Sinclair AJ, Rodriguez-Mañas L; Diabetes and Frailty: Two Converging Conditions? Can J Diabetes. 2016 Feb;40(1):77–83CrossRefPubMed Sinclair AJ, Rodriguez-Mañas L; Diabetes and Frailty: Two Converging Conditions? Can J Diabetes. 2016 Feb;40(1):77–83CrossRefPubMed
13.
Zurück zum Zitat Park SW1, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, de Rekeneire N, Harris TB, Schwartz AV, Tylavsky FA, Cho YW, Newman AB; Health, Aging, and Body Composition Study. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007 Jun;30(6):1507–12. Epub 2007 Mar 15.CrossRefPubMed Park SW1, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, de Rekeneire N, Harris TB, Schwartz AV, Tylavsky FA, Cho YW, Newman AB; Health, Aging, and Body Composition Study. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007 Jun;30(6):1507–12. Epub 2007 Mar 15.CrossRefPubMed
14.
15.
Zurück zum Zitat Rodríguez-Mañas L, Bayer AJ, Kelly M, Zeyfang A, Izquierdo M, Laosa O, Hardman TC, Sinclair AJ; MID-Frail Consortium. An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes—the MID-Frail study: study protocol for a randomised controlled trial. Trials. 2014 Jan 24;15:34CrossRefPubMedPubMedCentral Rodríguez-Mañas L, Bayer AJ, Kelly M, Zeyfang A, Izquierdo M, Laosa O, Hardman TC, Sinclair AJ; MID-Frail Consortium. An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes—the MID-Frail study: study protocol for a randomised controlled trial. Trials. 2014 Jan 24;15:34CrossRefPubMedPubMedCentral
Metadaten
Titel
Frailty – An emerging high impact complication of diabetes requiring specific management approaches
verfasst von
Alan Sinclair
B. Vellas
Publikationsdatum
12.01.2017
Verlag
Springer Paris
Erschienen in
The journal of nutrition, health & aging / Ausgabe 2/2017
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-017-0868-5

Weitere Artikel der Ausgabe 2/2017

The journal of nutrition, health & aging 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.